Skip to main content
NORTHEAST PHARMACEUTICAL GROUP CO.,LTD logo

NORTHEAST PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 000597 ISIN · CNE0000009G0 LEI · 300300HX6JTMOEENF158 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,606 across all filing types
Latest filing 2025-10-27 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 000597

About NORTHEAST PHARMACEUTICAL GROUP CO.,LTD

https://www.nepharm.com.cn

Northeast Pharmaceutical Group Co., Ltd. (NEPG) specializes in the research, development, manufacture, and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a large-scale integrated pharmaceutical enterprise with a diverse product portfolio encompassing vitamins, antibiotics, cardiovascular agents, and digestive system medications. NEPG is recognized as a global leader in the production of Vitamin C and Vitamin B1, alongside significant output in caffeine and fosfomycin. Its manufacturing facilities adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications. The company serves a broad international market, exporting products to numerous countries while maintaining a strong domestic presence. NEPG focuses on technological innovation and industrial scaling to provide high-quality chemical raw materials and pharmaceutical preparations for global healthcare needs.

Recent filings

Filing Released Lang Actions
证券投资管理制度
Governance Information Classification · 95% confidence The document is titled as a '证券投资管理制度' which translates to 'Securities Investment Management System' for the company. It outlines internal policies, principles, decision-making authority, risk control, supervision, and disclosure requirements related to securities investment by the company. It is a governance or internal control document rather than a financial report, earnings release, or announcement. It does not contain financial statements or results, nor is it a notice or announcement of a report. It is a detailed governance-related policy document issued by the board. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 2466 characters, which is relatively short but contains substantive governance content, not just an announcement or certification.
2025-10-27 Chinese
北京德恒律师事务所关于东北制药集团股份有限公司2022年限制性股票激励计划调整首次授予及预留授予回购价格的法律意见
Regulatory Filings
2025-10-27 Chinese
2025年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '东北制药集团股份有限公司2025 年第三季度报告' which translates to 'Northeast Pharmaceutical Group Co., Ltd. 2025 Third Quarter Report'. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial metrics for the third quarter of 2025. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the period. It also mentions that the report is unaudited, which is typical for interim or quarterly reports. The length of the document (over 12,000 characters) and the detailed financial content confirm it is the actual report, not just an announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q3 2025
2025-10-27 Chinese
关于拟变更会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the proposed change of the company's accounting firm for the 2025 fiscal year. It details the background, qualifications, and integrity of the new accounting firm, the communication with the previous firm, and the approval process by the board and audit committee. It does not contain any financial statements or audit reports themselves, but rather informs shareholders and the public about the change in auditor. The document length is 3215 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about auditor change and does not contain the audit report or financial data itself.
2025-10-27 Chinese
第十届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 7th meeting of the 10th Board of Directors of Northeast Pharmaceutical Group Co., Ltd. It includes details about the meeting date, attendance, voting results on various proposals, and references to other announcements and reports. The content focuses on board decisions, such as approval of the Q3 report, change of accounting firm, and adjustments to stock incentive plans. There is no detailed financial data or full report content here, only the announcement of board meeting resolutions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2025-10-27 Chinese
第十届监事会第四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Northeast Pharmaceutical Group Co., Ltd. It details the convening and voting results of the fourth meeting of the tenth Supervisory Board. The document references other announcements and reports (such as the 2025 Q3 report and auditor change announcement) but does not contain the reports themselves. It is a formal meeting resolution announcement, not a financial report or detailed management report. It is not a full Annual Report, Interim Report, or Earnings Release. It is also not a proxy solicitation or voting results announcement for shareholders but a Supervisory Board meeting resolution. Therefore, the best fitting category is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories. The document length is short (897 characters), consistent with an announcement rather than a full report.
2025-10-27 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.